Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

JAMA | Dec 24, 2021 Vaccine/Immunotherapy

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

The Lancet | Dec 23, 2021 Vaccine/Immunotherapy

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

PLoS Medicine | Dec 23, 2021 Vaccine/Immunotherapy

The impact of hepatitis B vaccination in the United States, 1999–2018

Hepatology | Dec 23, 2021 Vaccine/Immunotherapy

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study

PLoS Medicine | Dec 16, 2021 Vaccine/Immunotherapy

BNT162b2 vaccine booster and mortality due to COVID-19

New England Journal of Medicine | Dec 13, 2021 Vaccine/Immunotherapy

Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis

JAMA Neurology | Dec 13, 2021 Vaccine/Immunotherapy

Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among healthcare workers

JAMA | Dec 10, 2021 Vaccine/Immunotherapy

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

JAMA | Dec 10, 2021 Vaccine/Immunotherapy

Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries

JAMA | Dec 10, 2021 Vaccine/Immunotherapy

« Prev 1 2 3 4 5 … 42 Next »

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

The impact of hepatitis B vaccination in the United States, 1999–2018

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study

BNT162b2 vaccine booster and mortality due to COVID-19

Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis

Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among healthcare workers

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

SARS-CoV-2 antibodies after homologous vs heterologous third vaccine in kidney transplant recipients

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial

Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

The impact of hepatitis B vaccination in the United States, 1999–2018

Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study

BNT162b2 vaccine booster and mortality due to COVID-19

Association of disease-modifying treatment and anti-CD20 infusion timing with humoral response to 2 SARS-CoV-2 vaccines in patients with multiple sclerosis

Association of vaccine type and prior SARS-CoV-2 infection with symptoms and antibody measurements following vaccination among healthcare workers

Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older

Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

These Popular Snacks Linked a Decline in Mental Health

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Anaesthetic Management in Obese Patients

Select Specialty

Select Topic